Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACLIZUMAB vs DANAPAROID: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACLIZUMAB vs DANAPAROID: Safety Overview

Metric DACLIZUMAB DANAPAROID
Total FAERS Reports 2,801 170
Deaths Reported 193 67
Death Rate 6.9% 39.4%
Hospitalizations 835 75
Average Patient Age 45.7 yrs 63.4 yrs
% Female Patients 81.5% 63.1%
FDA Approval Date N/A Dec 24, 1996
Marketing Status Prescription Discontinued